OTCMKTS:POLXF Polydex Pharmaceuticals (POLXF) Stock Price, News & Analysis $1.99 +0.01 (+0.30%) As of 08/7/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Polydex Pharmaceuticals Stock (OTCMKTS:POLXF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get POLXF alerts:Sign Up Key Stats Today's Range$1.99▼$1.9950-Day Range$1.99▼$1.9952-Week Range$0.55▼$2.01Volume2,000 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewPolydex Pharmaceuticals Ltd. is a development stage company, which engages in manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, and the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market. The firm focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate and other specialty chemicals. The company was founded by Thomas C. Usher on June 14, 1979 and is headquartered in Toronto, Canada.Read More… Receive POLXF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Polydex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address POLXF Stock News HeadlinesPolydex Pharmaceuticals Limited Shareholders Vote to Approve BioSpectra Inc. Business CombinationJuly 18, 2023 | finance.yahoo.comPolydex Pharmaceuticals Limited: Polydex Pharmaceuticals Issues First Quarter Financial ResultsJune 15, 2023 | finanznachrichten.deElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.May 10, 2025 | Brownstone Research (Ad)Polydex Pharmaceuticals Limited and BioSpectra Inc. Announce Business CombinationApril 27, 2023 | finance.yahoo.comPolydex Pharmaceuticals Ltd.April 18, 2023 | barrons.comPolydex Pharmaceuticals GAAP EPS of -$0.09, revenue of $1.09MSeptember 17, 2022 | seekingalpha.comGlobal Computed Tomography (CT) Scanner Market to Reach $9.38 Billion by 2028 | Demand for AI based CT Scanner is On the RiseSeptember 16, 2022 | nz.finance.yahoo.comPolydex Pharmaceuticals LtdAugust 24, 2022 | reuters.comSee More Headlines POLXF Stock Analysis - Frequently Asked Questions How have POLXF shares performed this year? Polydex Pharmaceuticals' stock was trading at $1.9860 at the beginning of 2025. Since then, POLXF shares have increased by 0.0% and is now trading at $1.9860. View the best growth stocks for 2025 here. How do I buy shares of Polydex Pharmaceuticals? Shares of POLXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today5/10/2025Fiscal Year End1/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Industrial inorganic chemicals Sub-IndustryN/A Current SymbolOTCMKTS:POLXF CIK317158 Webwww.polydex.com Phone(416) 755-2231FaxN/AEmployees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$4.41 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (OTCMKTS:POLXF) was last updated on 5/10/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredWarning: Massive IPO Predicted for May 14?The #1 venture capitalist in America predicts that the biggest IPO in history will take place on Wednesday, Ma...Paradigm Press | SponsoredTrump’s Bitcoin Reserve is No Accident…Remember when they said crypto would never go mainstream? Well, something remarkable has happened… Blac...Crypto 101 Media | Sponsored[FREE GIFT] New AI for retail tradersTradeAlgo has found a “backdoor way” for retail traders to profit from the AI arms race by developing its grou...TradeAlgo | SponsoredOne Stock Gold Blueprint to Survive the Market ChaosOne Stock Gold Blueprint to Survive the Market Chaos Markets are volatile, uncertainty is everywhere, and A...InvestorPlace | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Polydex Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Polydex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy POLXF Stock Free POLXF Stock Alerts